vTv Therapeutics Inc. (NASDAQ: VTVT)
$14.0500
+0.0400 ( -5.67% ) 3.4K
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
Market Data
Open
$14.0500
Previous close
$14.0100
Volume
3.4K
Market cap
$36.60M
Day range
$14.2750 - $14.8950
52 week range
$7.3800 - $30.9900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 3 | Insider transactions | 4 | Jun 13, 2024 |
| 10-q | Quarterly Reports | 64 | May 09, 2024 |
| 8-k | 8K-related | 15 | May 09, 2024 |
| def | Proxies and info statements | 22 | Apr 25, 2024 |
| 8-k | 8K-related | 13 | Mar 26, 2024 |
| 8-k | 8K-related | 14 | Mar 14, 2024 |
| 3 | Insider transactions | 4 | Mar 14, 2024 |
| 10-k | Annual reports | 140 | Mar 13, 2024 |
| 8-k | 8K-related | 16 | Mar 13, 2024 |
| 4 | Insider transactions | 1 | Mar 07, 2024 |